Search results for: Innovation Policy Prize

Risk and Return in the Pharmaceutical Industry

1 August 1999

This book has been built up from the papers delivered at the Office of Health Economics conference which took place at the Langham Hilton Hotel, London, on 5 December 1996….

Trade Mark Legislation and the Pharmaceutical Industry

1 May 1999

A trade mark is, in its most basic sense, a badge of identity. Its most essential characteristic is its capacity to distinguish one undertaking’s goods or services from those of…

Themes

Themes OHE’s work is categorised into four broad themes. Economics of Innovation The development of innovative health technologies is essential for improving the quality and efficiency of health care provision….

Pharmaceuticals Among the Sunrise Industries

1 February 1984

The performance of the United Kingdom economy has been the subject of much critical comment in recent years. Of course, economic achievement can be viewed from many different perspectives, giving…

Pharmaceuticals in Developing Countries 1981-82

1 July 1984

Two years ago, the Office of Health Economics published a research paper describing some of the activities of eighteen European pharmaceutical companies in the Developing Countries in ·1979-80 (Worlock 1982)….

Pharmaceuticals in seven nations

1 May 1985

Great Britain at the suggestion of and in close collaboration with Medizinisch Pharmazeutische Studiengesellschaft (MPS) in the Federal Republic of Germany, OHE is funded entirely by the Association of the…

Biosimilar Competition: Lessons from Europe and Prospects for the US

1 October 2014

Based on an OHE lunchtime seminar by Professor Henry Grabowski, this seminar briefing explores the lessons learned from Europe’s experience with biosimilars, and provides an analysis of how the US…

Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK

1 March 2015

…Northern Ireland. The report highlights upcoming initiatives that may alter this landscape, describes three promising local programmes that demonstrate opportunities for expanding capabilities, and makes a series of policy recommendations….

International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective

1 May 2015

The OHE undertook an analysis of the uptake of medicines in 13 high income countries. The UK perspective on this was published in November 2014 by the ABPI. OHE has…